Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma
Clinical trial NCT00110123 · TERMINATED
Trial details
- NCT number
- NCT00110123
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2011-06-01
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.